Mar 26, 2025
21:20
For every 20 shares held, investors received 21. The price per share adjusted from $1935.00 to $1842.86.
The split itself did not change the total investment value.
Beta Drugs Ltd. (NSE:BETA) operates in the Pharmaceuticals: major industry.
Beta Drugs Ltd. company overviewBeta Drugs Ltd.'s most recent stock split was on March 26, 2025. It was a 21-for-20 forward split, so shareholders received 21 shares for every 20 they held.
Beta Drugs Ltd. has split its stock once. This history records one forward split, on March 26, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Beta Drugs Ltd.'s 21-for-20 split on March 26, 2025, every 20 shares became 21 shares.
Beta Drugs Ltd. has not announced a new split in our records. Its most recent split was on March 26, 2025, 1 year ago. Companies announce splits in advance, and any new NSE:BETA split will appear on this page.
Already premium?